Analytical Quality Control News

ECA Survey Results II: How is Statistical Process Control used in the Pharmaceutical Industry?

Phase 3 (ongoing/continued process verification) is the longest phase in the validation life cycle. Many companies use statistical process control (SPC) for this purpose. Concept Heidelberg conducted a survey for the ECA specifically on this topic. Among other things, the ECA wanted to know which control charts are used and what the limits are for cpk-values, etc. Read part II of the survey results summary. 

More
Eurachem Publishes New Guide on the Fitness for Intended Use of Analytical Equipment and Systems

Eurachem has published a new Guide titled The Fitness for Intended Use of Analytical Equipment and Systems – A Laboratory Guide to the Life Cycle of Analytical Equipment and Systems, their Qualification and Related Topics. The document addresses the entire life cycle and qualification of analytical equipment and systems used in laboratories, ranging from simple apparatus to complex computer-based systems, and promotes an integrated, risk-based approach to ensure fitness for intended use.

More
Analytical Quality Group Developments September through December 2025

Find out what the ECA Analytical Quality Control Group was working on and accomplished in the last four months of 2025 - in the latest report.

More
Your Input is Requested: AQCG Survey on OOS Investigations

How does your organization handle Out-of-Specification (OOS) results in practice? The ECA Analytical Quality Control Group (AQCG) invites you to share your experience and contribute to the ongoing update of AQCG OOS guidance. We would be pleased if you would participate in a short survey, which takes only a few minutes to complete.

More
Questions and Answers on System Suitability Tests (SST) - Part 2

During the ECA Live Online Training “System Suitability Tests (SST) and Troubleshooting for HPLC Methods” on 04 November 2025, participants raised a number of interesting, practice-oriented questions. These were subsequently answered in writing by the speakers’ team. To share selected insights with a wider audience, we have compiled a selection of these Q&As. Read Part 2 here.

More
EMA: Stability Data for Variations - Update to the Guideline

In December 2025, Revision 3 of the 'Guideline on stability testing for applications for variations to a marketing authorization' was published on the EMA website. It entered into force on 15 January 2026.

More
EDQM: New General Chapter 'Quality of Data' available

The new general chapter '5.38. QUALITY OF DATA' was made available in January with the release of version 12.3 of the European Pharmacopoeia (Ph. Eur. 12.3). This new chapter was open for public comment in 2024 and is scheduled to come into force in July 2026.

More
ECA Survey Results I: How is Statistical Process Control used in the Pharmaceutical Industry?

Phase 3 (ongoing/continued process verification) is the longest phase in the validation life cycle. Many companies use statistical process control (SPC) for this purpose. Concept Heidelberg conducted a survey for the ECA specifically on this topic. Among other things, the ECA wanted to know whether SPC is also used in other areas, which control charts are used, etc. Read the results of the survey in Part I. 

More
Become a Speaker at PharmaLab 2026 - Analytic, Bioanalytic, Microbiology

PharmaLab 2026 - become a speaker at the leading congress on analytics, bioanalytics and microbiology. Meet over 500 colleagues as part of the speaker team in Darmstadt (near Frankfurt Airport). We also welcome poster requests.

More
FDA Warning Letter: OOS Handling and HPLC Method Validation

When out-of-specification (OOS) laboratory results are explained rather than thoroughly investigated, and HPLC methods are not demonstrably fit for purpose, regulatory action may follow. A recent FDA Warning Letter highlights how recurring weaknesses in OOS handling and analytical method validation can result in significant CGMP compliance risks.

More
x